ARTICLE | Company News
Celsion, Zhejiang Hisun Pharmaceutical deal
February 18, 2013 8:00 AM UTC
Celsion said that Zhejiang Hisun does not plan to exercise its option to develop liver cancer compound ThermoDox in China and its territories. Hisun received the Chinese option to the doxorubicin enca...